Tech Company Financing Transactions
Anchor Therapeutics Funding Round
HealthCare Ventures, Novartis BioVenture Fund and TVM Capital participated in a $8 million Series A venture round for Anchor Therapeutics. This venture round was recorded on 11/2/2007.
Transaction Overview
Company Name
Announced On
11/2/2007
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
67 Rogers St. Bldg 600 - 6201
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Anchor Therapeutics develops pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease, and pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Stephen Hunt
President
Thomas McMurry
Browse more venture capital transactions:
Prev: 11/1/2007: Serious Energy venture capital transaction
Next: 11/2/2007: Vapotherm venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs